Adding a new dimension to its business, the Mukesh Ambani-led Reliance Life Sciences announced on Thursday its partnership with US-based global investment management firm, MPM Capital LP.
The partnership entails Reliance Life Sciences becoming a strategic partner in MPM Capital's newest fund, MPM BioVentures IV, which has a corpus of $650 million.
RLS will be a substantial investor in the fund besides acting as a strategic partner with the right to tap innovations in life sciences in the companies that the fund would be investing in.
Reliance Life Sciences' President and CEO K V Subramaniam said RLS would be investing a substantial double-digit
inline-block" id="div_arti_inline_advt">